April 01, 2014
4 min read
Save

Wavefront-guided myopic LASIK with new aberrometer yields predictable outcomes

Uncorrected distance visual acuity of 20/16 or better was achieved in 79% of eyes, and spherical equivalent was within 0.5 D of target in 93% of eyes.

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Wavefront-guided myopic LASIK with a new-generation Hartmann-Shack aberrometer yielded predictable outcomes and high patient satisfaction, according to a study.

The device also offered significant cylinder correction.

“The most significant result was the refractive and acuity outcomes,” Steven Schallhorn, MD, the corresponding author, said in an interview with Ocular Surgery News. “What undoubtedly contributed was the quality of the aberrometer and this aberrometer measurement combined with the ablation profile it generated. Those were contributing factors for the high level of efficacy in the study.”

The iDesign Advanced WaveScan aberrometer (Abbott Medical Optics) is not approved in the United States and is undergoing clinical trials. The study was conducted in the United Kingdom, Schallhorn said.

Steven C. Schallhorn, MD

Steven Schallhorn

The study was published in the Journal of Refractive Surgery.

Patients and procedure

The retrospective study included 243 eyes of 126 patients with a mean age of 34.5 years who underwent primary wavefront-guided LASIK.

The iDesign was used to capture wavefront data. An iFS femtosecond laser (AMO) or mechanical microkeratome was used to create LASIK flaps.

Schallhorn said that 82% of patients had femtosecond laser flaps and 18% had mechanical microkeratome flaps.

Ablation was performed with the Visx Star S4 IR excimer laser (AMO).

Investigators evaluated visual acuity, refraction and patient satisfaction 1 month after surgery.

Visual and refractive outcomes

Uncorrected distance visual acuity of 20/16 or better was attained in 79% of eyes, 20/20 or better in 93.4% and 20/25 or better in 96.7%. No eyes lost two or more lines of corrected distance visual acuity, and 14% of eyes gained two or more lines.

Manifest refraction decreased significantly (P < .01). Mean manifest spherical equivalent decreased from –3.28 D preoperatively to –0.03 D. Manifest spherical equivalent was within 0.5 D of emmetropia in 93% of eyes and within 1 D in 99.6%.

Mean manifest astigmatism decreased from –0.72 D to –0.14 D.

“The procedure incorporates a very precise rotational alignment on the eye prior to treatment with excimer laser,” Schallhorn said. “This combined with the improvement in the aberrometer and the creation of the unique treatment profile are responsible for the excellent outcomes. These excellent outcomes are also apparent for cylinder correction. Accurate cylinder correction is one of the standouts of the procedure.”

The authors noted that 98.5% of patients were satisfied with their outcomes.

Accurate ablation profile

Schallhorn attributed much of the accuracy to improvements in the aberrometer.

“It is a much more capable sensor,” he said.

“It has the ability to precisely sample all ocular aberrations across the entrance pupil,” he said. “It has the highest number of lenslets available in a Hartmann-Shack aberrometer. Then the internal algorithm calculates the ablation profile using an advanced Fourier reconstruction of the ocular aberrations. The ablation profile — in other words, the instructions provided to the excimer laser for where and when to place pulses on the cornea as well as the pulse size — is calculated in the aberrometer. This is a critical component to a wavefront-guided procedure and an important contributor to the high degree of efficacy.” – by Matt Hasson

Reference:
Schallhorn S, et al. J Refract Surg. 2014;doi:10.3928/1081597X-20131029-02.
For more information:
Steven Schallhorn, MD, can be reached at 11730 Caminito Prenticia, San Diego, CA 92131; email: scschallhorn@yahoo.com.
Disclosure: Schallhorn is a consultant for Abbott Medical Optics and global medical director for Optical Express.